摘要
在环境问题日益突出的背景下,学术界做了大量关于环境的研究。但鲜有文献说明不同类型环境规制政策的变化对医药制造业创新效率的影响。因此,文章基于费用型环境规制与投资型环境规制2种政策类型和2004—2016年中国27个省的面板数据,使用随机前沿(SFA)分析方法,实证研究了不同类型环境规制政策对医药制造业技术创新效率的影响。研究结果表明,费用型环境规制政策和投资型环境规制政策都对医药制造业的创新效率产生了"激励效应";在投资型环境规制中,建设项目"三同时"环保投资对医药制造业创新产出有正向作用;而工业污染源治理投资则对医药制造产业的创新作用不显著。
With the increasingly environmental issues,the academia has done a lot of research on the environmental regulation policies. However,there is little literature on the impact of different types of environmental regulation changes on the efficiency of pharmaceutical manufacturing innovation. Based on the panel data of 27 provinces in China from 2004 to 2016,this paper empirically studies the impact of different types of environmental regulation policies on technological innovation efficiency of pharmaceutical manufacturing industry. The results show that both the cost-based environmental regulation policy and the investment-based environmental regulation policy have an incentive effect on the innovation of pharmaceutical manufacturing industry,which supports the Porter hypothesis to some extent. In the investment-oriented environmental regulation,the"three simultaneous"environmental protection investment of construction projects has a great impact on the innovation of pharmaceutical manufacturing industry,while the investment in industrial pollution control has no significant effect on the innovation of enterprises.
引文
[1]董莉.中国医药制造业生态效率评价研究[J].石家庄经济学院学报,2016,39(04):93-97.
[2]马澜,朱佩枫.中国医药制造业产业结构与环境污染的灰色关联度分析[J].管理现代化,2015,35(09):61-63.
[3]章家清,张学芬.中国医药制造业技术创新能力实证研究[J].工业技术经济,2015,34(05):41-48.
[4]Stephens J K.Accounting for slower economic growth:the unified states in the 1970s[M].Guangxi:Normal University Press,2000.
[5]李玲,陶锋.中国制造业最优环境规制强度的选择---基于绿色全要素生产率的视角[J].中国工业经济,2012(05):70-82.
[6]张成,陆旸,郭路,等.环境规制强度和生产技术进步[J].经济研究,2011(10):117-119.
[7]Kneller R,Manderson E.Environmental regulations and innovation activity in UK manufacturing industries[J].Resource&Energy Economics,2012,34(02):211-235.
[8]Montalvo C C.Sustainable production and consumptionsystems-cooperation for change:assessing and simulating the willingness of the firm to adopt/develop cleaner technologies:the case of the In-bond industry in Northern Mexico[J].Journal of Cleaner Production,2003,11(04):17-19.
[9]Sun C,Kalirajan K P.Gauging the sources of growth of high-tech and low-tech industries:the case of Korean manufacturing[J].Australian Economic Papers,2005,44(02):170-185.
[10]李斌,彭星,陈柱华.环境规制、FIJI与中国治污技术创新---基于省际动态面板数据的分析[J].财经研究,2011(10):92-102.
[11]李小平,卢现祥,陶小琴.环境规制强度是否影响了中国工业行业的贸易比较优势[J].世界经济,2012(04):62-78.
[12]王杰,刘斌.环境规制与企业全要素生产率---基于中国工业企业数据的经验分析[J].中国工业经济,2014(03):44-56.
[13]Pannu H S,Dinesh Kumar U,Farooquie J A.Impact of innovation on the performance of indian pharmaceutical industry using data envelopment analysis[EB/OL].IIMBangalore Research Paper No.302,Available at SSRN:http://ssrn.com/abstract=2125785.
[14]Pannu H S,Dinesh Kumar U,Farooquie J A.Efficiency and productivity analysis of indian pharmaceutical industry using data envelopment analysis[J].International Journal of Operational Research,2011,10(01):121-136.
[15]张永庆,刘清华,徐炎.中国医药制造业研发效率及影响因素[J].中国科技论坛,2011(01):70-74.
[16]乌仔龙,张永安.基于SFA的区域战略性新兴产业创新效率分析---以北京医药和信息技术产业为例[J].科学与科学技术管理,2013(10):95-102.
[17]谭晓东,陈玉文.基于SFA方法的中国医药制造业创新效率评价[J].中国新药杂志,2016,25(13):1461-1465.
[18]曹阳,张文思.我国医药制造业创新效率及其影响因素的空间计量分析[J].中国新药杂志,2017,26(12):1351-1356.
[19]刘忠敏,马文婷.基于网络SBM-Malmquist模型的医红制造业创新效率及影响因素研究[J].科技管理研究,2017,37(12):152-158.
[20]樊玉录,陈玉文.基于向量自回归模型的政府资金投入对企业研发产出的影响研究---以中国医药制造业为例[J].沈阳药科大学学报,2019,36(01):77-84.
[21]章成帅.中国高技术产业创新效率研究---一个文献综述[J].中国科技论坛,2016(04):56-62.
